Our new understanding of heart failure: the role of beta-blockers in treatment.
Beta-blockers, long considered contraindicated in heart failure, improve left ventricular function in this disease by improving the biology of cardiac myocytes. Whether they improve survival remains to be determined.
Department of Internal Medicine (Cardiology Division), University of Texas Southwestern, Dallas, USA. eichhorn@ryburn.swmed.edu
E J
EJ
Eichhorn
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006333:Heart Failure / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D011379:Prognosis; D015996:Survival Rate; D016896:Treatment Outcome
D000319:Adrenergic beta-Antagonists